ONKOMEDIA - Informationsmaterial

ONKOMEDIA Expert Video

Zur Übersicht

Begrüßung und Vorstellung der Videoreihe

Aufbau und Entwicklung von ADCs

Sacituzumab Govitecan im mTNBC Effektivität und Nebenwirkungsprofil

Effektivität und Sicherheit von Sacituzumab Govitecan (SG) beim hormonrezeptor-positiven Mammakarzinom

T-DXd mTNBC HER2low Efficacy und Safety

T-DXd HR+ HER2low Efficacy und Safety

ADCs in special populations

Antikörper-Medikamenten-Konjugate Nebenwirkungsmanagement

Antikörper-Wirkstoff-Konjugate: Ausblick

ONKOMEDIA Expert Statement

Zur Übersicht

Sicherheitsprofil von Antikörper-Wirkstoff-Konjugaten (ADCs) in der Brustkrebstherapie

ONKOMEDIA Medizinische Illustrationen

Zur Übersicht

ADC_Circulation

ADC_Linker Stability

ADC_Milestones in ADC payload development

ADC_Molecular components of ADCs

ADC_Rationale for ADC-based combination therapies

ADC_Sacituzumab Govitecan

ADC_Timeline History

Antibody Drug Conjugates

Facts and Figures_Breast cancer histological subtypes

Facts and Figures_Breast cancer intrinsic subtypes

Facts and Figures_Breast cancer US numbers

Facts and Figures_Common metastatic sites in breast cancer

Facts and Figures_Common side effects in breast cancer treatment

Facts and Figures_Tumor localization by frequency and sex AUT numbers

Facts and Figures_Tumor localization by frequency and sex US numbers

Facts&Figures

MoA-Mode of Action

Mode of Action_Antibody Drug Conjugate

Mode of Action_Capecitabine

Mode of Action_Capivasertib

Mode of Action_Cdk4-6 Inhibitors

Mode of Action_Combination of targeted therapies and antiestrogen theraies

Mode of Action_Doxorubicin

Mode of Action_ER targeted therapy

Mode of Action_Eribulin

Mode of Action_Gemcitabine

Mode of Action_HER-2 targeted therapy

Mode of Action_Hormone therapies

Mode of Action_Immune checkpoint inhibitors

Mode of Action_PARP Inhibitors

Mode of Action_PD(L)-1 Inhibitors

Mode of Action_Sacituzumab Govitecan

Mode of Action_Taxane

Mode of Action_Topoisomerase 1 inhibition

Pathology & Histology_ER and PR expression

Pathology & Histology_HER2 testing

Pathology & Histology_Prevalence of HER2-low

Trop2_Domain Organization

Trop2_Trop-2 overexpression in cancer

Trop2_Trop-2 Signaling